BSE · EIKO
EIKO LIFESCIENCES LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,183
of 5,088 stocks
▲ 751W
Peak #3,160 · 27 Sep 2026
Operating in Healthcare, EIKO LIFESCIENCES LIMITED is growing revenue rapidly, trades at a moderate earnings multiple, and posts a modest return on equity.
Market Cap
71.39 Cr
P/E Ratio
15.26
P/B Ratio
1.02
ROE
7.63%
ROCE
9.99%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 16.75 Cr | 18.34 Cr | 11.98 Cr | 11.67 Cr |
| Net Profit | 1.51 Cr | 1.50 Cr | 1.43 Cr | 1.28 Cr |
| EPS | 0.91 | 0.93 | 0.88 | 0.78 |
| Operating Profit | 2.09 Cr | 2.16 Cr | 1.94 Cr | 1.77 Cr |
Shareholding pattern
Promoter
39.91%
Public
60.09%
PUBLIC BREAKDOWN
Individuals
43.35%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 07 Jul 2023 | Other | Right Issue of Equity Shares |
| 20 Sep 2017 | Dividend | Dividend - Rs. - 0.2500 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.